1. Home
  2. Browse
  3. Diabetes & Endocrinology
  4. Diabetes
  5. Treatment

Treatment

241 - 255 of 323 Results
Sort Results:
Commentary: Metformin vs Pioglitazone for Polycystic Ovary Syndrome May 2011
Commentary: Cycloset: A New Bromocriptine Formulation for Diabetes February 2011
Commentary: Restricted Use of Rosiglitazone Products (Avandia, Avandamet, and Avandaryl) December 2010
Article: More diabetes patients will use insulin pumps December 2010
Article: Patients will be asking what to do now that rosiglitazone (Avandia, etc) use is being restricted December 2010
Article: possible link between Actos (pioglitazone) and bladder cancer October 2010
Commentary: Actos (Pioglitazone) and Risk of Bladder Cancer October 2010
Other: See new Health Canada information concerning the restricted use of Avandia August 2010
Article: whether Avandia is riskier than Actos August 2010
Commentary: Cardiovascular Safety of Rosiglitazone (Avandia) – 2010 Update August 2010
Patient Education: Avandia and Risk of Heart Attack August 2010
Commentary: New Drug: Victoza (Liraglutide) July 2010
Article: Victoza (liraglutide) is the first NON-insulin injectable med for type 2 diabetes July 2010
Commentary: Cross-Reactivity of Sulfonamide Drugs June 2010
Article: Ongoing concerns about Avandia (rosiglitazone) April 2010